AMC clinical physiologist Peter Sterk’s idea to explore the use of e-nose technology for diagnosis of lung disease has really payed off. His brand-new ‘SpiroNose’ breath analyser will shortly become available for hospitals and general practices. Sterk is confident about the clinical validation studies that are now underway: “The SpiroNose will be a formidable addition to the diagnosis of asthma, COPD, lung cancer and other pulmonary diseases. It offers a fast and reliable first assessment, even without testing blood or sputum. Since we integrated it with common spirometry, it comes without any additional effort for the patient.” With the aid of IXA the SpiroNose was developed in cooperation with the Dutch specialist e-nose firm Comon Invent.
With multiple sensors it profiles a few thousand molecules in the patient’s exhaled air. These data are then analysed in real-time by comparing them with thousands of other profiles stored online in a ‘BreathCloud’, employing Artificial Intelligence based self-learning algorithms. Although he did not foresee all this at the onset of his research, Sterk was more than happy to put a lot of effort in developing the SpiroNose. “That’s how it goes: an idea leads to a research project for which an instrumental set-up is needed. In fact there you already have the germination of a new product. Because if the research leads to clinically relevant results, of course you then want to make the set-up available for as much doctors as possible!”
Apply existing eye-tracking technology for the development of a state-of-the art digital instrument for orthoptic strabismus measurements. This clever idea by physicist Bob van Dijk is now nearly a reality with Laméris Ootech, a Dutch supplier of orthoptic practice equipment. In his office at VUmc Van Dijk proudly demonstrates his almost perfectly functioning prototype. “A […]
The academic incubator facility Amsterdam Venture Studios has found its place in the heart of five campus locations in Amsterdam (Startup Village on Amsterdam Science Park, LawHub on Roeterseiland, AVS VU Campus, AVS Humanities Lab on City Centre Campus, HvA Venture Centre at the campus in Zuidoost and AVS ahti near AMC also in Zuidoost). […]
There is not yet a vaccine against the second deadliest infection in the world after tuberculosis: HIV. Rogier Sanders and Godelieve de Bree of the Amsterdam UMC are optimistic about the possibility of developing one now. It’s for the first time that a vaccine is being developed in one hospital (Amsterdam UMC) from the design […]